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Ryoto Hirasawa, Hozo Hashimoto, Shinya Makino, Shuso Suemaru, Toshihiro
Takao, Zensuke Ota, Yoshihiko Hoshida, Tadashi Yoshino, and Tadaatsu Akagi
Abstract
A 46-year-old woman with acromegaly and hyperthyroidism due to a pituitary adenoma. She
had high serum thyroid-stimulating hormone (TSH) levels and very high serum growth hormone
(GH) levels. Transsphenoidal removal of the tumor, post-operative irradiation, frontal craniotomy
for removal of residual tumor and large-dose bromocriptine therapy were carried out consecu-
tively. After therapy, serum GH levels gradually decreased, but not to the normal range, and serum
TSH levels remained at inappropriately normal levels. Using immunoperoxidase techniques, GH-,
TSH- and follicle-stimulating hormone (FSH)-containing cells were demonstrated in the adenoma.
A long-acting somatostatin analogue (SMS 201-995, 600 micrograms/day) suppressed the serum
GH level to the normal range with a concomitant suppression of TSH. Furthermore, the paradox-
ical serum GH responses to TRH and LH-RH were slightly improved. No important subjective
side-effects were noted. Therefore, SMS 201-995 appeared to be a very effective drug in this
patient with a GH- and TSH-producing pituitary tumor.
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